BRIEF-Outlook Therapeutics Announces Preliminary Topline Results Of Norse Eight Clinical Trial

Reuters
27 Nov 2024

Nov 27 (Reuters) - Outlook Therapeutics Inc OTLK.O:

  • OUTLOOK THERAPEUTICS® ANNOUNCES PRELIMINARY TOPLINE RESULTS OF NORSE EIGHT CLINICAL TRIAL

  • OUTLOOK THERAPEUTICS INC -ANTICIPATE RESUBMISSION OF BLA IN CALENDAR Q1 2025

  • OUTLOOK THERAPEUTICS INC - ONS-5010 DID NOT MEET NON-INFERIORITY ENDPOINT IN NORSE EIGHT TRIAL

  • OUTLOOK THERAPEUTICS INC - FINAL EFFICACY DATA EXPECTED IN JANUARY 2025

Source text: ID:nGNX8RHkkB

Further company coverage: OTLK.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."